Veriti Management LLC Vertex Pharmaceuticals Inc Transaction History

Veriti Management LLC

$1.83 Billion
Q3 2024

A detailed history of Veriti Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Veriti Management LLC holds 5,868 shares of VRTX stock, worth $2.4 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,868

Previous 5,533 6.05%

Holding current value

$2.4 Million

Previous $2.59 Million 5.24%

% of portfolio

0.15%

Previous 0.16%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$460.0 - $505.78 $154,100 - $169,436	335 Added 6.05%	5,868 $2.73 Million
Q2 2024 Aug 02, 2024	BUY	$392.81 - $485.53 $555,826 - $687,024	1,415 Added 34.36%	5,533 $2.59 Million
Q1 2024 Apr 19, 2024	BUY	$407.69 - $446.08 $271,521 - $297,089	666 Added 19.29%	4,118 $1.72 Million
Q4 2023 Feb 05, 2024	BUY	$343.0 - $410.68 $406,798 - $487,066	1,186 Added 52.34%	3,452 $1.4 Million
Q3 2023 Oct 27, 2023	BUY	$338.18 - $362.46 $73,046 - $78,291	216 Added 10.54%	2,266 $787,000
Q2 2023 Jul 13, 2023	BUY	$314.42 - $351.91 $82,692 - $92,552	263 Added 14.72%	2,050 $721,000
Q1 2023 Apr 26, 2023	BUY	$283.23 - $323.1 $25,773 - $29,402	91 Added 5.37%	1,787 $563,000
Q4 2022 Jan 20, 2023	BUY	$285.76 - $321.48 $285 - $321	1 Added 0.06%	1,696 $0
Q3 2022 Oct 26, 2022	BUY	$273.83 - $305.53 $45,729 - $51,023	167 Added 10.93%	1,695 $491,000
Q2 2022 Jul 18, 2022	BUY	$234.96 - $292.55 $24,905 - $31,010	106 Added 7.45%	1,528 $431,000
Q1 2022 Apr 11, 2022	BUY	$221.42 - $260.97 $32,105 - $37,840	145 Added 11.35%	1,422 $371,000
Q4 2021 Jan 19, 2022	BUY	$177.01 - $223.45 $7,788 - $9,831	44 Added 3.57%	1,277 $280,000
Q3 2021 Oct 08, 2021	SELL	$181.39 - $202.99 $56,593 - $63,332	-312 Reduced 20.19%	1,233 $224,000
Q2 2021 Jul 13, 2021	SELL	$187.49 - $221.1 $176,615 - $208,276	-942 Reduced 37.88%	1,545 $312,000
Q1 2021 Apr 14, 2021	SELL	$207.02 - $241.31 $298,729 - $348,210	-1,443 Reduced 36.72%	2,487 $534,000
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $813,549 - $1.09 Million	3,930 New	3,930 $929,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.

Account

Veriti Management LLC Vertex Pharmaceuticals Inc Transaction History